Matthew Blomstedt

The discussion focused on clarifying the governance structure of Nebraska Medicine following Clarkson Regional Health Services' decision to withdraw as a partner. The speaker detailed the history, including the 1997 joint operating agreement leading to dual ownership, which was strengthened in 2016. The transition involves the University of Nebraska Board of Regents becoming the sole member, a model tested in other academic medical centers. Key financial aspects include the transfer of approximately $300 million in real estate and the $500 million sale of the clinical enterprise. Clarkson has committed a $200 million philanthropic investment into Project Health for the future health professions home. It was emphasized that this transition will not convert Nebraska Medicine into a state hospital, nor will it affect employee status (remaining Nebraska Medicine employees or dual employees) or impact academic budgets or tuition. The finalization of the arrangement is targeted for on or before the end of June 2026.

The meeting primarily consisted of public comments directed toward a proposed transaction involving Clarkson Regional Health and Nebraska Medicine. Speakers, including the chair and CEO of the Nebraska Medicine Board of Directors, expressed strong opposition to the transaction, citing concerns that it was not in Nebraska Medicine's best interests, lacked transparency, and violated contractual rights regarding negotiation involvement. Key arguments focused on the potential loss of Nebraska Medicine's operational independence, the undisclosed $800 million funding details, and the risk of Nebraska Medicine's resources being used to subsidize university tuition costs or facility monetization through rent charges. Speakers requested the Board reject the transaction and negotiate an alternative structure preserving Nebraska Medicine's independence. A representative from Clarkson College also voiced concerns regarding funding competition, potential negative impacts on healthcare education, and the confusion caused by the proposed changes among constituents.

The Board meeting commenced with the official call to order and roll call. Key agenda items included a presentation by Senator John Arch regarding the 2026 Legislative Session, and the presentation of awards, specifically the National Champion of Science Award to Senator Deb Fischer and KUDOS awards to several university staff members. The Board moved into a closed session to discuss Real Estate Transactions and Honorary Degrees and Awards. In the open session, President Gold provided an update on the University, welcomed the newest Regent, and discussed the financial situation and budgeting process. Public comment was received regarding proposed changes to Standing Rule 5.1.1. The University Consent Agenda covered President's Personnel Recommendations, approval of process regarding debt obligations, and amendments to the Audit, Risk and Compliance Committee Charter. The University Administrative Agenda addressed the elimination of several academic programs and the establishment of new majors and certificates at the University of Nebraska at Omaha (UNO). Further administrative actions included the approval of Honorary Degrees and Awards, Prime Supplier agreements for Food and Related Items at UNL, the Banking Services License Agreement between UNL and Union Bank and Trust Company, facility naming, and the approval of design information and budget revision for a research building addition at UNO. Finally, amendments to Regents' Policies and Standing Rules were approved, while a proposed addition to the Standing Rules failed to pass. Numerous reports were presented for information only, concluding with adjournment.

The Special Board of Regents meeting included public comments primarily focused on opposing a proposed transaction involving the University of Nebraska's purchase of Clarkson Regional Health Shares of Nebraska Medicine. Speakers from Nebraska Medicine, including the Board Chair and CEO, voiced strong opposition, emphasizing concerns over the loss of Nebraska Medicine's independence, the proposed $800 million funding mechanism, potential diversion of resources from patient care to subsidize university costs like tuition, and the lack of meaningful engagement with Nebraska Medicine's leadership during negotiations. Speakers requested the Board reject the transaction and negotiate an alternative structure preserving independence. A representative from Clarkson College also expressed concerns regarding confusion caused by the transaction and the potential negative impact on healthcare education and workforce development if the current successful independent structure is altered.

The meeting commenced with the pledge of allegiance and the calling of the roll. The board approved the minutes from the January 15, 2026 meeting. A significant portion of the meeting involved an address by Speaker of the Nebraska Legislature, Senator John Arch, who discussed the current state budget challenges stemming from mandated revenue reductions, such as income tax stepping down and social security/military retirement exemptions from state income tax. He expressed optimism for future growth and highlighted past legislative support for university initiatives, including expansions in nursing, rural health education, behavioral health, pancreatic cancer research, the Agriculture Innovation Facility, and internship programs. Following the Speaker's remarks, Senator Deb Fischer was recognized and presented with the National Champion of Science Award for her significant advocacy for federally funded scientific research at the university across agriculture, health, national security, and transportation safety sectors.